Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 May 1;157(5):1529-43.
doi: 10.1084/jem.157.5.1529.

Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation

Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation

M Howard et al. J Exp Med. .

Abstract

In this report we describe conditions for polyclonal activation of small numbers of highly purified mouse B lymphocytes. Three signals are required for induction of DNA synthesis by the particular subset of small B lymphocytes investigated: a signal delivered by antibodies specific for the IgM receptor expressed on the B cell membrane; a signal delivered by a T cell-derived factor (B cell growth factor [BCGF]); and a signal delivered by the macrophage-derived factor interleukin 1 (IL-1). The conclusion that IL-1 has B cell co-stimulator activity is based on the findings that highly purified preparations of mouse and human IL-1 have the capacity to cause proliferation in B cells treated with anti-IgM and BCGF. Such cultures show an absolute dependence on exogenously added IL-1 when 2-mercaptoethanol is omitted from the medium. BCGF and IL-1 each act in a non-antigen-specific, non-H-2-restricted, synergistic manner. Their requirement is not observed when B cells are cultured at high density, presumably reflecting accessory cell contamination and endogenous factor production under these conditions. The B cell activation induced by these three signals is restricted to proliferation without the production of antibody-forming cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Experientia. 1967 Apr 15;23(4):271-2 - PubMed
    1. J Exp Med. 1972 Jul 1;136(1):128-42 - PubMed
    1. Transplant Rev. 1972;8:76-103 - PubMed
    1. Scand J Immunol. 1974;3(2):133-46 - PubMed
    1. J Immunol. 1974 Sep;113(3):925-33 - PubMed

Publication types